Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLibertine Hold Regulatory News (LIB)

  • This share is currently suspended. It was suspended at a price of 1.165
  • There is currently no data for LIB

Appointment of Auditors

28 Apr 2022 07:01

RNS Number : 5953J
Libertine Holdings PLC
28 April 2022
 

28 April 2022

Libertine Holdings PLC

("Libertine" or the "Company")

 

Change of Auditor

 

The Board of Libertine Holdings PLC has appointed Crowe U.K. LLP ("Crowe") as its new independent auditor with immediate effect.

 

The Board has approved the appointment of Crowe as the Company's auditor for the financial year ended 31 March 2022. The re-appointment of Crowe for the financial year ending 31 March 2023 will be subject to approval by shareholders at the next Annual General Meeting of the Company to be held later in 2022.

 

In accordance with Section 519 of the Companies Act 2006, the Company's previous auditor, RSM UK Audit LLP, has deposited with the Company a statement confirming that there are no matters to be brought to the attention of the Company's members or creditors.

 

 

For further information please contact:

 

Libertine Holdings PLC

via Tavistock

Sam Cockerill, Chief Executive Officer

Gareth Hague, Chief Financial Officer

 

 

 

Panmure Gordon (NOMAD and Broker)

+44 20 7886 2500

John Prior

Ailsa Macmaster

Hugh Rich (Corporate Broking)

Tavistock (Public Relations and Investor Relations)

+44 207 920 3150 

Simon Hudson

libertine@tavistock.co.uk

Rebecca Hislaire

Nick Elwes 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPBKOBDABKDKQB
12
Date   Source Headline
30th Sep 20247:00 amRNSCancellation - Libertine Holdings plc
28th Aug 20243:44 pmRNSAppointment of Administrators & Nomad Resignation
19th Aug 20247:00 amRNSFinancing Update
7th Aug 20242:00 pmRNSEngagement of Interpath Advisory
31st Jul 20242:18 pmRNSFinancing Update
29th Jul 20241:02 pmRNSFinancing Update & Suspension of Trading in Shares
29th Jul 202412:50 pmRNSSuspension - Libertine Holdings plc
16th Jul 20247:00 amRNSFinancing Update
1st Jul 20247:00 amRNSFinancing Update
20th Jun 20244:38 pmRNSFinancing Update
13th Jun 20247:00 amRNSUpdate on Strategic Review & Formal Sale Process
5th Jun 20249:31 amRNSForm 8.5 (EPT/RI)
28th May 20248:35 amRNSForm 8.5 (EPT/RI)
24th May 20249:47 amRNSForm 8.5 (EPT/RI)
21st May 20244:30 pmRNSUpdate on Strategic Review & Formal Sale Process
21st May 20241:09 pmRNSForm 8.3 - Libertine Holdings plc
17th May 20242:33 pmRNSForm 8.3 - Libertine Holdings plc
16th May 20242:36 pmRNSForm 8.3 - Libertine Holdings plc
13th May 202410:03 amRNSForm 8.5 (EPT/RI)
13th May 20247:00 amRNSStrategic Partnership Agreement with Vieletech Inc
10th May 202410:07 amRNSForm 8.3 - Libertine Holdings plc
8th May 20242:49 pmRNSForm 8.3 - Libertine Holdings plc
8th May 202412:52 pmGNWForm 8.3 - Libertine Holdings plc
3rd May 20247:00 amRNSForm 8 (OPD) (Libertine Holdings plc)
30th Apr 202410:50 amRNSForm 8 (OPD) (Libertine Holdings plc)
30th Apr 20247:06 amRNSForm 8.3 - Libertine Holdings plc
29th Apr 20249:23 amRNSForm 8.5 (EPT/RI)
29th Apr 20247:00 amRNSStrategic Review & Formal Sale Process
25th Mar 20247:00 amRNSStrategic Partnership Agreement with LHP
22nd Mar 202412:21 pmRNSTrading Update
12th Mar 20247:00 amRNSStrategic Partnership Agreement with BASEBATT
9th Feb 20244:07 pmRNSHolding(s) in Company
7th Feb 20246:30 pmRNSCompletion of support and license to Hyliion
19th Dec 20237:00 amRNSHalf year results
15th Dec 20237:00 amRNSNotice of Results
10th Nov 20237:00 amRNSResult of AGM
9th Nov 20237:00 amRNSTrading Update
6th Oct 20231:39 pmRNSNotice of Annual Report and Annual General Meeting
28th Sep 20237:00 amRNSFinal Results
26th Sep 20237:00 amRNSNotice of Results
1st Sep 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSTrading Update
22nd Feb 20237:00 amRNSImplementation of Long Term Incentive Plan
16th Feb 20237:00 amRNSSigning of Term Sheet with Azelio AB
13th Jan 20233:56 pmRNSHolding(s) in Company
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
15th Dec 20227:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.